Andrew Herr is the founder and CEO of Flykitt (and its parent company Fount), a health and human-performance company that builds systems to eliminate jet lag by targeting circadian disruption and travel-induced inflammation. Before entrepreneurship, he spent over a decade advising the U.S. military on human performance and biotech strategy from the Pentagon's Office of Net Assessment, working with Navy SEALs and fighter pilots. Holding three Georgetown master's degrees and twice named an Army 'Mad Scientist,' Herr has turned the performance secrets of special operators into products trusted by pro sports teams, executives, and everyday travelers.
David Matthews, PhD, is Chief Business Officer at Beacon Biosignals, the computational neurodiagnostics company turning EEG brain data into AI-powered biomarkers for neurological and psychiatric disease. A computational neuroscientist by training, he spent two decades moving between the lab, the boardroom, and the market - from NIH- and NSF-funded research at the Salk Institute to a partnership at Boston Consulting Group to commercial leadership at digital-health platform BrightInsight. He now drives partnerships and commercial growth at a company betting that the brain can be measured at home, at scale.